impact of recession on your business
Dermatology Devices Market

Dermatology Devices Market Size, Share & Segment by Product type (Diagnostic Devices (Imaging devices, Dermato scopes, Microscopes), Treatment Devices (Electrosurgery Devices, Cryotherapy Devices, Laser Devices), By Application type (Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, Warts), By End user type (Hospitals, Clinics), by Regions and Global Forecast 2022-2028

Report Id: SNS/HC/2570 | July 2022 | Region: Global | 135 Pages

Report Scope & Overview:

Dermatology Devices Market Size was valued at USD 7.15 billion in 2021, and expected to reach USD 15.62 billion by 2028, and grow at a CAGR of 11.8% over the forecast period 2022-2028.

Devices for dermatology are used to treat skin conditions. Dermatology deals with serious skin problems, arrangements, decisions, illnesses, or concerns connected to cosmetic issues. Lasers, RF equipment, microdermabrasion tools, and other ancillary items are examples of dermatology devices. These tools are put in hospitals and dermatological offices to help medical professionals and non-medical practitioners identify skin cancer and treat skin problems.

Dermatology Devices Market Revenue Graph

MARKET DYNAMICS

DRIVERS

  • Skin conditions are becoming more common

  • More cosmetic procedures being performed

  • Advancements in technology

  • More money being spent on healthcare

RESTRAINTS

  • Medical devices are subject to strict regulatory policies.

  • Uncertainty and problems with reimbursement

OPPORTUNITIES

  • Economies in transition

CHALLENGES

  • The Dermatology Devices Market is being threatened by low-cost manufacturers' aggressive pricing strategies and the availability of low-cost alternatives.

IMPACT OF COVID-19

The development and expansion of the Dermatology Diagnostic Devices Market were interrupted by the coronavirus sickness. It led to numerous businesses closing down around the world for several months. This has considerably accelerated market growth and sparked a trend toward internet shopping. However, this element started to serve as a growth factor. Nevertheless, market opening and developments by industry participants will resume will further boost market expansion.

By Product type

The diagnostic and therapy segments of the dermatological device market are separated. During the projection period, the segment for treatment devices is anticipated to generate the largest revenue. This is explained by the increase in demand for dermatology tools that aid in disease management. Additionally, an increase in surgical operations using these dermatology devices would fuel market expansion over the next years. However, it is anticipated that diagnostic devices would account for sizable revenue shares in the dermatology devices market.

By Application type

The diagnosis of skin cancer, psoriasis, skin rejuvenation, and warts are the segments of the dermatological devices industry. Due to the rising incidence of skin cancer, which requires early diagnosis, the skin cancer diagnosis segment is expected to generate the most revenue during the projection period. The segment would also produce bigger revenue shares in the upcoming years thanks to expanding studies on skin cancer diagnosis for treating skin-related disorders.

By End user type

The hospitals, clinics, and other segments of the market for dermatology devices. Due to an increase in the number of outpatients who prefer clinics, it is predicted that the clinics category would generate the most income throughout the forecast period. In the coming years, the segment will also earn a sizeable market share because to the availability of experienced specialists for performing diagnostics and increasing investments made by specialty clinics to adopt cutting-edge product kinds.

COMPETITIVE LANDSCAPE

Some of the major key players are as follows: Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc., Cynosure Inc., Michelson Diagnostics Ltd., Lumenis Ltd., Valeant Pharmaceuticals

MARKET SEGMENT

By Product type

  • Diagnostic Devices

    • Imaging devices

    • Dermatoscopes

    • Microscopes

  • Treatment Devices

    • Electrosurgery Devices

    • Cryotherapy Devices

    • Laser Devices

By Application type

  • Skin Cancer Diagnosis

  • Psoriasis

  • Skin Rejuvenation

  • Warts

By End user type

  • Hospitals

  • Clinics

Dermatology Devices Market Segment Chart

REGIONAL ANALYSIS

The dermatology device market is expected to be dominated by North America, with other regions following. Improvements in healthcare infrastructure, services provided to emerging nations, and an increase in public health awareness are just a few of the reasons why North America holds a higher market share. In North America as a whole, both developing and developed regions are expected to experience a rapid increase in demand for dermatology equipment in the future years.

REGIONAL COVERAGE

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Dermatology Devices Market Report Scope:
Report Attributes Details
Market Size in 2021 US$ 7.15 Billion
Market Size by 2028 US$ 15.62 Billion
CAGR CAGR of 11.8% From 2022 to 2028
Base Year 2021
Forecast Period 2022-2028
Historical Data 2017-2020
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product type (Diagnostic Devices (Imaging devices, Dermato scopes, Microscopes), Treatment Devices (Electrosurgery Devices, Cryotherapy Devices, Laser Devices)
• By Application type (Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, Warts)
• By End user type (Hospitals, Clinics)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc., Cynosure Inc., Michelson Diagnostics Ltd., Lumenis Ltd., Valeant Pharmaceuticals
Key Drivers • Skin conditions are becoming more common
• More cosmetic procedures being performed
RESTRAINTS • Medical devices are subject to strict regulatory policies.
• Uncertainty and problems with reimbursement


Frequently Asked Questions (FAQ) :

Ans. The forecast period of Dermatology devices market is 2022 to 2028.

Ans Medical devices are subject to strict regulatory policies, and Uncertainty and problems with reimbursement is the restraints of Dermatology devices Market.

Ans the impact of covid on Dermatology devices Market have a negative impact.

Ans. Ambicare Health, 3Derm Systems Inc., Cuter Inc., Alma Lasers Ltd., Candela Corporation, Galderma S.A., V. Genentech Inc. are the key players of the Dermatology devices Market

Ans. Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, and Warts are the sub segment of by application.


Table of Content:

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID 19 Impact Analysis

4.2 Impact of Ukraine ware

 

5. Value Chain Analysis

 

6. Porter’s 5 forces model

 

7.  PEST Analysis

  

8. Dermatology devices Market Segmentation, By Product type

8.1 Diagnostic Devices

8.1.1 Imaging devices

8.1.2 Dermatoscopes

8.1.3 Microscopes

8.2 Treatment Devices

8.2.1 Electrosurgery Devices

8.2.2 Cryotherapy Devices

8.2.3 Laser Devices

 

9. Dermatology devices Market Segmentation, By Application type

9.1 Skin Cancer Diagnosis

9.2 Psoriasis

9.3 Skin Rejuvenation

9.4 Warts

 

10. Dermatology devices Market Segmentation, By End user type

10.1 Hospitals

10.2 Clinics

 

11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Germany

11.3.2 UK

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 The Netherlands

11.3.7 Rest of Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 South Korea

11.4.3 China

11.4.4 India

11.4.5 Australia

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 Israel

11.5.2 UAE

11.5.3 South Africa

11.5.4 Rest

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Rest of Latin America

 

12.Company Profiles

12.1 Ambicare Health

              12.1.1 Financial

12.1.2 Products/ Services Offered

12.1.3 SWOT Analysis

12.1.4 The SNS view

12.2 3Derm Systems Inc.

12.3 Cuter Inc.

12.4 Alma Lasers Ltd.

12.5 Candela Corporation

12.6 Galderma S.A.

12.7 V. Genentech Inc.

12.8 Cynosure Inc.

12.9 Michelson Diagnostics Ltd.

12.10 Lumenis Ltd.

 

13.Competitive Landscape

13.1 Competitive Benchmark

13.2 Market Share analysis

13.3 Recent Developments

 

14.Conclusion

 

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.

Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.